Additionally, a flow cytometry study analyzing the phenotypic profile of circulating immune cells in AD found that the proportion of immune cells expressing CCR5 was higher in AD patients than in age-matched controls and that CCR5 was more highly expressed on CD4+ versus CD8+ T cells (51). This evidence concerns the gene CCR5 and Alzheimer disease.